Neoadjuvant PD-1 Blockade Plus Platinum-based Chemotherapy for EGFR-mutant NSCLC (CTONG2104): An Interim AnalysisC. Zhang, D. -C. Yi,Y. -X. Sun,B. -Y. Jiang, L. -X. Yan, L. -S. Peng,S. -Y. Liu, J. Yang,H. Sun, D. Peng,Y. -S. Li, S. -A. Chen,R. -Q. Liao,X. -N. Yang,Q. Zhou,Y. -L. Wu,Z. -M. Zhang, W. -Z. ZhongJOURNAL OF THORACIC ONCOLOGY（2023）引用 0|浏览0暂无评分关键词NSCLC,EGFR,ImmunotherapyAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
